By contrast, typical molecular alterations of these tumours include gain-of-function mutations in GNAQ, GNA11, PLCB4 or CYSLTR2 as well as chromosomal alterations including gains on chromosome arms 8q and 6p as well as losses on chromosome arms 1p and 6q [39]. Here, GNA11 is linked to neoplasm.